BMO Capital Downgrades Nevro Corp (NVRO) to Market Perform (Earlier)

BMO Capital analyst Joanne Wuensch downgraded Nevro Corp (NYSE: NVRO) from Outperform to Market Perform with a price target of $46.00.

"The problem seems to be OUS, with commentary for US growth to offset international declines given Australian reimbursement changes. It is getting harder to support: downgrading NVRO to Market Perform from Outperform," the analyst commented.

For an analyst ratings summary and ratings history on Nevro Corp click here. For more ratings news on Nevro Corp click here.

Shares of Nevro Corp closed at $47.38 yesterday.

You May Also Be Interested In

• Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
• Roth/MKM Downgrades Tigo Energy (TYGO) to Neutral
• BMO Capital Downgrades The Trade Desk (TTD) to Market Perform